Nightingale Appoints an Experienced Executive to lead its efforts in Quebec and the North American Consumer eHealth Market

- The Company hires Mr. Luc Sirois to further strengthen its presence in Quebec and accelerate its penetration of  the consumer eHealth market

MARKHAM, ON, Jan. 17, 2012 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) "Nightingale" or "Company", an application service provider (ASP) of electronic medical record (EMR) software and related services today announced the appointment of Luc Sirois to the role of Vice President and General Manager for Quebec, effective immediately.

As Vice President and General Manager, Mr. Sirois will be responsible for building Nightingale's presence in the Quebec (EMR) market, establishing relationships and partnerships with leading edge clinics, healthcare providers and other healthcare technology vendors and for bringing Nightingale's expertise to the province.  Mr. Sirois' appointment follows Nightingale's December 2011 acquisition of assets related to Medrium Inc's Practice Management software business, which included a development team in Quebec City. The Quebec City-based development team will play a significant role in leading Nightingale's technology innovation and development plans in Quebec and across North America.

In addition to his leadership position in Quebec, Mr. Sirois will also take on the role of Vice President of Consumer eHealth for North America. He will oversee the Company's further penetration of the growing consumer eHealth market, through the expansion of Nightingale's Patient Access offering and the introduction of other patient-centric products and services.

A respected industry veteran, Mr. Sirois has more than 15 years of experience in the Healthcare IT market, helping organizations launch innovative technologies.  Most recently, he served as Vice President of Consumer Health at a major Canadian telecommunication company, where he launched consumer eHealth offerings and spearheaded other healthcare IT initiatives.  Before his role in the telecommunication industry, Mr. Sirois was Vice President of Business Development and Chief Operating Officer at Telesystem and Plexo, where he managed a network of clinics, medical labs, radiology centres and corporate medical services.  Mr. Sirois was also the co-founder of Resonant Medical, a leading provider of image-guided radiotherapy equipment that was sold to Elekta Medical in 2009.  Mr. Sirois has an undergraduate degree from McGill University and an MBA from Harvard Business School.

"We believe Luc's leadership and industry experience will serve as valuable assets as we continue to strengthen our foothold in Quebec and work to further penetrate the consumer eHealth market," said Mr. John Bodolai, Executive Vice President of Nightingale. "With plans to soon launch our bilingual EMR, Quebec is an important target market for us.  We are excited about furthering our investment in the province and adding breadth and depth to our Quebec-based team."

"Nightingale is committed to helping physicians enhance patient healthcare," said Mr. Sirois. "I am a firm believer that the type of innovation we are bringing to market will shape, in many ways, the way medical practices will function in the future.  With access to more than 6,000,000 patients through its existing customer base of healthcare practitioners, Nightingale is already in an enviable position to make a real difference in the quality of patient care and the physician-patient relationship; not only nationally, but in North-America."

The addition of Mr. Sirois to the Nightingale management team is part of the Company's strategy to leverage its investments in a bilingual platform across the country. Nightingale was recently awarded a multimillion dollar contract by the Association of Ontario Health Centers to deploy a bilingual platform to 3,500 healthcare providers over a two-year period.

About Nightingale Informatix Corporation (www.nightingalemd.com)

Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) and patient portals the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected.

Forward-Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully integrate its acquisitions and any liabilities arising as a result of such acquisitions, access to capital and agreements with its Lenders; the existence of present and possible future government regulation; access to debt or equity financing and agreements with its Lenders; the significant and increasing competition that exists in the medical software industry; the early stage of Nightingale's business; and therefore it is subject to the risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Although management believes the assumptions used to make such statements are reasonable at this time, our assumptions may not to be as anticipated, estimated or intended. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding Nightingale's continued ability to fund its business, rates of customer defaults, relationships with, and payments to, lenders, demand for Nightingale's products, as well as Nightingale's operating cost structure.

Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Media Inquiries
Sharmeen Arafat
Marketing Manager
905.307.3617
[email protected]

Investor Inquiries
Kristen Dickson, M.Sc.
Equicom, a TMX Group Company
Tel: [phone] ext. 273
[email protected]m